This inventor holds 22 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Peptide Therapeutics. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The United States of America as Represented by the Department of Health, Georgetown University. Active years: 1988-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- West Bethesda, MD (US) (1988)
- Bethesda, MD (US) (1993 - 2021)
Company Filing History:
16 out of 3,696 
5 out of 1,217 
2 out of 499 
Years Active: 1988-2021
Areas of Expertise:
Title: Innovator Spotlight: Terrence R. Burke, Jr. – Pioneer in Anticancer Therapeutics
Introduction: Terrence R. Burke, Jr. is a prominent inventor based in Bethesda, MD, renowned for his groundbreaking work in the field of anticancer therapeutics. With an impressive portfolio of 22 patents, his innovations focus on peptide and peptide mimetic binding antagonists, which play a crucial role in cancer treatment.
Latest Patents: Among his latest patented innovations, Burke has developed compounds that serve as antagonists of the polo-like kinase 1 (Plk1) polo box domain. One notable patent details novel compounds capable of binding to polo-like kinases, demonstrating improved efficacy in biochemical assays against Plk1. These peptide derivatives include macrocyclic peptidomimetics with high affinity and selectivity that can potentially establish a new genre of anticancer therapeutics. Moreover, Burke's work also introduces bi-valent compounds with dual binding capabilities to both the kinase domain and the polo-box domain of Plk1, significantly enhancing their affinity and therapeutic potential.
Another significant patent involves PEGylated peptides that bind to the polo-box domain of polo-like kinases, showcasing high binding affinity and activity in whole cell systems. This innovation includes methods of design and synthesis for these PEGylated peptides, along with their uses in therapeutic applications.
Career Highlights: Terrence R. Burke, Jr. has had affiliations with esteemed organizations such as the United States Department of Health and Human Services, where his expertise has contributed to advancing healthcare through scientific innovations. His commitment to developing targeted cancer treatments is evident through his patent contributions.
Collaborations: Throughout his career, Burke has collaborated with notable coworkers including Yang Gao and Zhu-jun Yao. These partnerships highlight the collaborative nature of scientific research and the importance of multidisciplinary teams in innovation.
Conclusion: Terrence R. Burke, Jr. stands out as a leading innovator in the field of anticancer therapeutics. His inventive contributions through numerous patents continue to pave the way for future advancements in cancer treatment, demonstrating the profound impact of dedicated researchers in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile